Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2025
Effectiveness of mailed versus in-person PAP initiation in the Veterans Affairs' TeleSleep program.
СтатьяСравнительное исследованиеПоддержка исследования: вне правительства СШАПоддержка NIH: внешняя программаНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gomez Alexander, Sarmiento Kathleen F, Smith Connor, Mitchell Michael, Lee Diane, Totten Annette, Sanders Elizabeth, Ryden Armand M, Seo Jiyeon, Bhattacharyya Sarathi, Harris Brian, Mempin Roberto, Moghtaderi Isabel, Jawed Yameena, Jambulingam Nikita, Martin Jennifer, Zeidler Michelle
Аннотация
STUDY OBJECTIVES: This study sought to evaluate whether telehealth setup was noninferior to in-person setup for veterans initiating positive airway pressure (PAP) therapy.
METHODS: PAP setups before and after the COVID-19 pandemic were identified at 2 Veterans Affairs health systems. Telehealth PAP setups occurred between March 2020 and December 2021. The in-person PAP setups occurred between January and December 2019. PAP data were extracted for days 1-30 (month 1) and 60-90 (month 3). PAP use was compared between in-person and telemedicine using hours used per night, days used (out of 30 days), and residual apnea-hypopnea index (among adherent users). Noninferiority analyses were performed, using the following noninferiority margins: 45 minutes for hours used, 4 days for days of usage, and 5 events/h for residual apnea-hypopnea index.
RESULTS: A total of 432 Veterans Affairs patients (93.5% male) who underwent PAP setup were included (224 in-person; 208 telehealth). Noninferiority was established for PAP usage at month 1 (90% confidence interval [CI] = -0.31, 0.53) and month 3 (90% CI = -0.18, 0.71), days used at month 1 (90% CI = -2.28, 1.33) and month 3 (90% CI = -1.75, 2.20), and residual apnea-hypopnea index at month 1 (90% CI = -0.40, 1.62) and month 3 (90% CI = -0.69, 2.30).
CONCLUSIONS: Initiation of PAP therapy via telehealth was noninferior to in-person setup visits in terms of PAP adherence among veterans who use Veterans Affairs care.
CITATION: Gomez A, Sarmiento KF, Smith C, et al. Effectiveness of mailed versus in-person PAP initiation in the Veterans Affairs' TeleSleep program. J Clin Sleep Med. 2025;21(8):1379-1387.
METHODS: PAP setups before and after the COVID-19 pandemic were identified at 2 Veterans Affairs health systems. Telehealth PAP setups occurred between March 2020 and December 2021. The in-person PAP setups occurred between January and December 2019. PAP data were extracted for days 1-30 (month 1) and 60-90 (month 3). PAP use was compared between in-person and telemedicine using hours used per night, days used (out of 30 days), and residual apnea-hypopnea index (among adherent users). Noninferiority analyses were performed, using the following noninferiority margins: 45 minutes for hours used, 4 days for days of usage, and 5 events/h for residual apnea-hypopnea index.
RESULTS: A total of 432 Veterans Affairs patients (93.5% male) who underwent PAP setup were included (224 in-person; 208 telehealth). Noninferiority was established for PAP usage at month 1 (90% confidence interval [CI] = -0.31, 0.53) and month 3 (90% CI = -0.18, 0.71), days used at month 1 (90% CI = -2.28, 1.33) and month 3 (90% CI = -1.75, 2.20), and residual apnea-hypopnea index at month 1 (90% CI = -0.40, 1.62) and month 3 (90% CI = -0.69, 2.30).
CONCLUSIONS: Initiation of PAP therapy via telehealth was noninferior to in-person setup visits in terms of PAP adherence among veterans who use Veterans Affairs care.
CITATION: Gomez A, Sarmiento KF, Smith C, et al. Effectiveness of mailed versus in-person PAP initiation in the Veterans Affairs' TeleSleep program. J Clin Sleep Med. 2025;21(8):1379-1387.